Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2011424.pdf
Reference33 articles.
1. Abel EV, Aplin AE . (2010). FOXD3 is a mutant B-RAF-regulated inhibitor of G1/S progression in melanoma cells. Cancer Res 70: 2891–2900.
2. Aplin AE, Kaplan FM, Shao Y . (2011). Mechanisms of resistance to RAF inhibitors in melanoma. J Invest Dermatol 131: 1817–1820.
3. Boisvert-Adamo K, Aplin AE . (2006). B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis. Oncogene 25: 4848–4856.
4. Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H et al. (2010). Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467: 596–599.
5. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J et al. (2011). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364: 2507–2516.
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A twenty year perspective on melanoma therapy;Pigment Cell & Melanoma Research;2023-09-28
2. A Network of MicroRNAs and mRNAs Involved in Melanosome Maturation and Trafficking Defines the Lower Response of Pigmentable Melanoma Cells to Targeted Therapy;Cancers;2023-01-31
3. Cooperative induction of receptor tyrosine kinase s contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway;Cancer Reports;2022-10-17
4. Mitochondrial dysfunction interferes with neural crest specification through the FoxD3 transcription factor;Pharmacological Research;2021-02
5. Transcriptomic Alterations Induced By Vemurafenib after Treatment of Melanoma: A Comprehensive Bioinformatics Analysis;Indian Journal of Pharmaceutical Sciences;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3